Cemvita, a frontrunner in industrial biotechnology focused on establishing a scalable circular bioeconomy, has announced two significant developments aimed at bolstering its ability to translate validated lab results into reliable industrial performance. The company has completed a complementary technology acquisition that broadens its intellectual property and scale-up capacity, alongside appointing Dr. Luciano Zamberlan as Vice President of Operations, who will be based in Brazil. These initiatives are designed to enhance operational readiness and deepen Cemvita’s technical and execution capabilities within the region.
"These steps enable us to augment Brazil’s longstanding bioindustrial ecosystem with next-generation capabilities, reducing early commercialization risk and expanding optionality for future product platforms," stated Marcio Silva, CTO of Cemvita.
The technology acquisition introduces additional synthetic biology tools and intellectual property, as well as strain expertise that will shorten commercialization timelines. When combined with committed operational leadership on the ground, these enhancements are expected to bolster confidence regarding near-term delivery milestones, commissioning, and consistent product supply within a sustainable value chain.
Cemvita has recently reported notable improvements in FermOil™ bioprocess productivity and received strong third-party validation of FermNatural™ co-product attributes, both of which contribute positively to the project's economics and market positioning. Additionally, the company has progressed the engineering workflow of FermWorks™ with local Brazilian partners towards a Final Investment Decision (FID). Concurrently, Cemvita has advanced its industrial strategy in Rio Grande do Sul, aligning feedstock availability, local infrastructure, and public-sector support to create a clear pathway to commercial operation.
"Together, they strengthen our ability to move from proof-of-concept to industrial reality," added Silva.
Dr. Luciano Zamberlan will lead the operational execution, site readiness, and early commissioning efforts from Brazil. With over 20 years of biotechnology experience, he previously served as Director of Engineering at Raízen, Brazil’s largest ethanol producer. There, he oversaw large-scale projects from concept to operation, including the implementation of four greenfield plants focused on second-generation ethanol and biogas. His commitment to innovation and sustainability includes integrating multidisciplinary teams to maximize financial outcomes while minimizing environmental impacts.
"I am very pleased to join Cemvita, a company at the forefront of transforming waste into valuable, sustainable resources. My expertise in scaling-up innovation, coupled with my experience in structuring and commissioning greenfield industrial operations, is perfectly aligned with Cemvita's mission and I'm eager to bring my energy and drive to accelerate Cemvita's industrial performance and contribute for a circular future," expressed Zamberlan.
These strategic investments in technology and operations aim to expedite the conversion of validated science into repeatable industrial performance, enhancing options across sustainable aviation fuel, biofertilizer, and specialty chemical pathways while improving capital efficiency and delivery certainty for collaborators. Cemvita remains committed to disciplined execution, focusing on transforming technology milestones into reliable supply and measurable impact.
Cemvita, a frontrunner in industrial biotechnology focused on establishing a scalable circular bioeconomy, has announced two significant developments aimed at bolstering its ability to translate validated lab results into reliable industrial performance. The company has completed a complementary technology acquisition that broadens its intellectual property and scale-up capacity, alongside appointing Dr. Luciano Zamberlan as Vice President of Operations, who will be based in Brazil. These initiatives are designed to enhance operational readiness and deepen Cemvita’s technical and execution capabilities within the region.
"These steps enable us to augment Brazil’s longstanding bioindustrial ecosystem with next-generation capabilities, reducing early commercialization risk and expanding optionality for future product platforms," stated Marcio Silva, CTO of Cemvita.
The technology acquisition introduces additional synthetic biology tools and intellectual property, as well as strain expertise that will shorten commercialization timelines. When combined with committed operational leadership on the ground, these enhancements are expected to bolster confidence regarding near-term delivery milestones, commissioning, and consistent product supply within a sustainable value chain.
Cemvita has recently reported notable improvements in FermOil™ bioprocess productivity and received strong third-party validation of FermNatural™ co-product attributes, both of which contribute positively to the project's economics and market positioning. Additionally, the company has progressed the engineering workflow of FermWorks™ with local Brazilian partners towards a Final Investment Decision (FID). Concurrently, Cemvita has advanced its industrial strategy in Rio Grande do Sul, aligning feedstock availability, local infrastructure, and public-sector support to create a clear pathway to commercial operation.
"Together, they strengthen our ability to move from proof-of-concept to industrial reality," added Silva.
Dr. Luciano Zamberlan will lead the operational execution, site readiness, and early commissioning efforts from Brazil. With over 20 years of biotechnology experience, he previously served as Director of Engineering at Raízen, Brazil’s largest ethanol producer. There, he oversaw large-scale projects from concept to operation, including the implementation of four greenfield plants focused on second-generation ethanol and biogas. His commitment to innovation and sustainability includes integrating multidisciplinary teams to maximize financial outcomes while minimizing environmental impacts.
"I am very pleased to join Cemvita, a company at the forefront of transforming waste into valuable, sustainable resources. My expertise in scaling-up innovation, coupled with my experience in structuring and commissioning greenfield industrial operations, is perfectly aligned with Cemvita's mission and I'm eager to bring my energy and drive to accelerate Cemvita's industrial performance and contribute for a circular future," expressed Zamberlan.
These strategic investments in technology and operations aim to expedite the conversion of validated science into repeatable industrial performance, enhancing options across sustainable aviation fuel, biofertilizer, and specialty chemical pathways while improving capital efficiency and delivery certainty for collaborators. Cemvita remains committed to disciplined execution, focusing on transforming technology milestones into reliable supply and measurable impact.